IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.
Melanoma represents the most aggressive and the deadliest form of skin cancer. Current therapeutic approaches include surgical resection, chemotherapy, photodynamic therapy, immunotherapy, biochemotherapy, and targeted therapy.
The following lists anti-cancer drugs, US FDA and Indian Generic brand approved by the Food and Drug Administration (FDA) for Melanoma treatment. The list includes generic and brand names are in some way related to, or used in the treatment of this condition. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
AGRYLIN ® (anagrelide hydrochloride) Capsules. 0.5 mg capsules for oral administration.
More Details...KIMMTRAK (tebentafusp-tebn) injection, for intravenous use Initial U.S. Approval: 2022
More Details...OPDUALAG (nivolumab and relatlimab-rmbw) injection, for intravenous use Initial U.S. Approval: 2022
More Details...DEFITELIO (defibrotide sodium) injection, for intravenous use Initial U.S. Approval: 2016
More Details...ELDISINE * (Vindesine Sulphate). Eldisine Powder for Solution for Injection 5.0 mg.
More Details...NPLATE ® (romiplostim) for injection, for subcutaneous use Initial U.S. Approval: 2008
More Details...TEPADINA ® (thiotepa) for injection, for intravenous, intracavitary, or intravesical use. Initial U.S. Approval: 1959
More Details...Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi, New Delhi:110016 India.
We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.
Indian Pharma Network is registered medical pharmacy for Oncology Products in India.Helps you to access FDA approved Melanoma medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Melanoma Medicines in China, UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
If you have a question relating to anti-cancer medicines approved for treatment of Melanoma, a problem which you do not know how to resolve it, or concrete inquiry - we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.
The list includes US FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.
IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.
The list includes US FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.
IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.
The list includes FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.
IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.